S. 1041

Status: Passed Senate

Affordable Prescriptions for Patients Act

Sponsored by John Cornyn (Republican-TX)

Topics

Cosponsors

Actions

Roll calls

Amendments

Related bills

Actions

Jul 21, 2026 · Library of Congress

Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.

Jul 21, 2026 · Senate

Passed Senate with amendments by Unanimous Consent. (consideration: CR S4198-4199; text: CR S4199)

Jul 21, 2026 · Senate

Message on Senate action sent to the House.

Jul 21, 2026 · House floor actions

Received in the House.

Jul 21, 2026 · House floor actions

Held at the desk.

Apr 10, 2025 · Library of Congress

Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.

Apr 10, 2025 · Senate

Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.

Apr 10, 2025 · Senate

Placed on Senate Legislative Calendar under General Orders. Calendar No. 44.

Apr 3, 2025 · Senate

Committee on the Judiciary. Ordered to be reported with amendments favorably.

Mar 13, 2025 · Library of Congress

Introduced in Senate

Mar 13, 2025 · Senate

Read twice and referred to the Committee on the Judiciary.

Latest activity

July 2026

Lobbying reported · Families USA Foundation · Jul 30

Families USA Foundation reported 2nd Quarter (Apr 1 - June 30) lobbying for Families USA Foundation — $9,000

BillsH.R. 6248 H.R. 7973 H.R. 8317 H.R. 9392 H.R. 9397 H.R. 9644 H.R. 9831 H.R. 9832 H.R. 9833 H.Res. 1268 S. 527 S. 958 S. 1040 S. 1041 S. 1096 S. 1954 S. 2355 S. 3014

Lobbying reported · Whitmer & Worrall · Jul 22

Whitmer & Worrall reported 2nd Quarter (Apr 1 - June 30) lobbying for Campaign For Sustainable Drug Pricing (csrxp) — $50,000

BillsH.R. 1262 H.R. 1843 H.R. 3160 H.R. 3269 H.R. 3789 H.R. 4570 H.R. 5526 H.R. 6485 S. 43 S. 1032 S. 1040 S. 1041 S. 1096 S. 1414 S. 1546 S. 1954 S. 2658 S. 3014

Lobbying reported · Todd Strategy Group · Jul 21

Todd Strategy Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Pfizer — $60,000

BillsS. 1040 S. 1041

Lobbying reported · Biotechnology Innovation Organization · Jul 21

Biotechnology Innovation Organization reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $2,360,000

Lobbying reported · America's Health Insurance Plans (ahip) · Jul 20

America's Health Insurance Plans (ahip) reported 2nd Quarter (Apr 1 - June 30) lobbying for America's Health Insurance Plans (ahip) — $3,010,000

BillsH.R. 1 H.R. 247 H.R. 379 H.R. 584 H.R. 608 H.R. 610 H.R. 842 H.R. 935 H.R. 950 H.R. 957 H.R. 1096 H.R. 1117 H.R. 1157 H.R. 1162 H.R. 1397 H.R. 1403 H.R. 1523 H.R. 1614 H.R. 1627 H.R. 1775 H.R. 1776 H.R. 1805 H.R. 1867 H.R. 1899 H.R. 1924 H.R. 2013 H.R. 2045 H.R. 2049 H.R. 2079 H.R. 2199 H.R. 2309 H.R. 2433 H.R. 2450 H.R. 2528 H.R. 2533 H.R. 2553 H.R. 2554 H.R. 2571 H.R. 2586 H.R. 2610 H.R. 2636 H.R. 2741 H.R. 3000 H.R. 3023 H.R. 3069 H.R. 3415 H.R. 3493 H.R. 3527 H.R. 3546 H.R. 3701 H.R. 3789 H.R. 3808 H.R. 4093 H.R. 4206 H.R. 4231 H.R. 4313 H.R. 4317 H.R. 4406 H.R. 4559 H.R. 4605 H.R. 4623 H.R. 4641 H.R. 4710 H.R. 5081 H.R. 5145 H.R. 5243 H.R. 5281 H.R. 5371 H.R. 5509 H.R. 5526 H.R. 5582 H.R. 5584 H.R. 6010 H.R. 6232 H.R. 6248 H.R. 6255 H.R. 6361 H.R. 6703 H.R. 6951 H.R. 6974 H.R. 7023 H.R. 7064 H.R. 7164 H.R. 7189 H.R. 7409 H.R. 7537 H.R. 7727 H.R. 7778 H.R. 7787 H.R. 7790 H.R. 7803 H.R. 7837 H.R. 7871 H.R. 8270 H.R. 8375 H.R. 8377 H.R. 8684 H.R. 8779 H.R. 8875 H.R. 9393 H.R. 9504 S. 339 S. 483 S. 526 S. 529 S. 652 S. 717 S. 729 S. 752 S. 864 S. 882 S. 891 S. 931 S. 939 S. 976 S. 1040 S. 1041 S. 1056 S. 1082 S. 1096 S. 1227 S. 1261 S. 1414 S. 1637 S. 1753 S. 1816 S. 1818 S. 1847 S. 1954 S. 1973 S. 2237 S. 2289 S. 2345 S. 2355 S. 2356 S. 2497 S. 2556 S. 2620 S. 2658 S. 2709 S. 2903 S. 3014 S. 3599 S. 3642 S. 3690 S. 3727 S. 3729 S. 3750 S. 3751 S. 3762 S. 3822 S. 3829 S. 3834 S. 3848 S. 3886 S. 3990 S. 4189 S. 4332 S. 4355 S. 4384 S. 4509 S. 4512

Lobbying reported · Pharmaceutical Care Management Association · Jul 20

Pharmaceutical Care Management Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Care Management Association — $3,282,990

Lobbying reported · Association for Accessible Medicines · Jul 20

Association for Accessible Medicines reported 2nd Quarter (Apr 1 - June 30) lobbying for Association for Accessible Medicines — $870,000

BillsH.R. 3160 H.R. 3269 H.R. 5526 H.R. 5811 H.R. 6485 H.R. 7148 H.R. 8269 H.R. 8339 S. 43 S. 1041 S. 1096 S. 1414 S. 1546 S. 1553 S. 1954 S. 2658 S. 3469 S. 3788

Lobbying reported · Blue Cross And Blue Shield Of Florida · Jul 20

Blue Cross And Blue Shield Of Florida reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Of Florida — $80,000

Lobbying reported · Blood Cancer United · Jul 20

Blood Cancer United reported 2nd Quarter (Apr 1 - June 30) lobbying for Blood Cancer United — $590,000

Lobbying reported · Amgen · Jul 20

Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000

Lobbying reported · Johnson & Johnson Services · Jul 20

Johnson & Johnson Services reported 2nd Quarter (Apr 1 - June 30) lobbying for Johnson & Johnson Services — $1,440,000

Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20

Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000

Lobbying reported · American Intellectual Property Law Association · Jul 20

American Intellectual Property Law Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Intellectual Property Law Association — $10,000

BillsH.R. 1109 H.R. 1566 H.R. 2675 H.R. 3160 H.R. 3269 H.R. 4930 H.R. 5794 H.R. 5811 H.R. 6028 H.R. 6485 H.R. 6517 H.R. 7140 S. 43 S. 1041 S. 1096 S. 1367 S. 1546 S. 1553 S. 1833 S. 2677 S. 3517

Lobbying reported · Novartis · Jul 20

Novartis reported 2nd Quarter (Apr 1 - June 30) lobbying for Novartis — $1,410,000

Lobbying reported · Blue Cross And Blue Shield Association · Jul 20

Blue Cross And Blue Shield Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Association — $990,000

Lobbying reported · Guidewell Mutual Holding · Jul 20

Guidewell Mutual Holding reported 2nd Quarter (Apr 1 - June 30) lobbying for Guidewell Mutual Holding — $20,000

Lobbying reported · Council for Innovation Promotion · Jul 20

Council for Innovation Promotion reported 2nd Quarter (Apr 1 - June 30) lobbying for Council for Innovation Promotion — $90,000

BillsH.R. 861 H.R. 2794 H.R. 3269 H.R. 4370 H.R. 4780 H.R. 6485 H.R. 9221 H.R. 9474 S. 43 S. 527 S. 1040 S. 1041 S. 1367 S. 2140 S. 2220 S. 2780 S. 4840

Lobbying reported · Blue Cross Blue Shield Of Michigan · Jul 20

Blue Cross Blue Shield Of Michigan reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross Blue Shield Of Michigan — $276,347

Lobbying reported · Radius Advocacy · Jul 19

Radius Advocacy reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $30,000

BillsS. 1040 S. 1041 S. 2658

Lobbying reported · Radius Advocacy · Jul 19

Radius Advocacy reported 2nd Quarter (Apr 1 - June 30) lobbying for Council for Innovation Promotion — $50,000

BillsH.R. 3160 S. 1040 S. 1041 S. 1553 S. 2658